Kang Wenyu, Ding Zhengrong, Shen Liping, Zhao Zhixian, Huang Guofei, Zhang Jie, Xiong Qing, Zhang Shuang, Zhang Shuo, Wang Feng
Center for Disease Control and Prevention of Yunnan Province, Kunming 650022, China.
National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Vaccine. 2014 Jun 5;32(27):3362-6. doi: 10.1016/j.vaccine.2014.04.045. Epub 2014 Apr 29.
To explore the risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus (HBV) and hepatitis B vaccination status in Yunnan province, China.
Multicenter cluster sampling was used to select pregnant women who were positive for hepatitis B surface antigen (HBsAg). HBV immunoprophylaxis was carried out for the newborns. Blood samples were collected and tested for HBV markers from 7 to 10 month old infants. The factors were analyzed by univariate and logistic regression.
A total of 2765 mothers and their infants were enrolled. The failure rate of prevention of mother to child transmission (PMTCT) was 4.12%. The rate of timely HepB1 vaccination within 24h was 98.04%, the rate of three-dose vaccination was 92.30% and the rate of hepatitis B immune globulin (HBIG) administration was 68.97%. Place of residence, maternal education, gestational age and birth weight were related to administration of HBV immunoprophylaxis. It was remarkable that the rate of HBIG administration of infants was only 63.89% with whose mothers were both HBsAg and hepatitis B e antigen (HBeAg)-positive. Further analysis showed that there were three risk factors associated with HBV immunoprophylaxis failure: mothers who were positive for HBsAg and HBeAg, maternal HBVDNA level, and HBIG administration or not.
PMTCT of HBV was well implemented in Yunnan. However, in order to achieve optimal prevention of vertical HBV transmission, it is mandatory to make additional efforts to improve the implementation of regulatory HBV immunoprophylaxis, especially for HBsAg-positive pregnant women.
探讨中国云南省乙型肝炎病毒(HBV)母婴传播免疫预防失败及乙肝疫苗接种状况的相关危险因素。
采用多中心整群抽样方法选取乙型肝炎表面抗原(HBsAg)阳性的孕妇。对新生儿进行HBV免疫预防。采集7至10月龄婴儿的血样并检测HBV标志物。通过单因素分析和逻辑回归分析相关因素。
共纳入2765对母婴。母婴传播阻断(PMTCT)失败率为4.12%。出生24小时内及时接种第1剂乙肝疫苗的比例为98.04%,全程3剂接种率为92.30%,乙肝免疫球蛋白(HBIG)注射率为68.97%。居住地、母亲文化程度、孕周和出生体重与HBV免疫预防措施的实施有关。值得注意的是,母亲HBsAg和乙肝e抗原(HBeAg)均阳性的婴儿,其HBIG注射率仅为63.89%。进一步分析显示,与HBV免疫预防失败相关的危险因素有3个:母亲HBsAg和HBeAg阳性、母亲HBV DNA水平以及是否注射HBIG。
云南省HBV母婴传播阻断工作实施良好。然而,为实现最佳的HBV垂直传播预防效果,必须进一步努力加强规范的HBV免疫预防措施的实施,尤其是针对HBsAg阳性孕妇。